IvrWell-12

ITC-HSN: 901890

2.55 / NOS

Min Order Qty 1 NOS

Accept Small Orders

  • Product not available

IvrWell-12 contains Ivermectin 12 mg, a trusted antiparasitic medication widely recognized in global markets for its effectiveness and safety. It is used to treat and control a range of parasitic infections in humans, offering reliable therapeutic outcomes across diverse healthcare settings.

Key Highlights of IvrWell-12


  • Composition: Ivermectin 12 mg tablet
  • Therapeutic Use: Effective against intestinal worms, scabies, and other parasitic infections
  • Global Demand: High export potential due to its broad-spectrum efficacy and established clinical use
  • Quality Standards: Grade Pharmacy product manufactured in WHO-GMP and ISO-certified facilities.
  • Market Advantage: Competitive pricing, consistent supply, and strong regulatory documentation support global distribution
  • Packaging: Export-friendly, customizable packaging options available for different market requirements

IvrWell-12 is a reliable, high-quality antiparasitic product that meets pharmaceutical standards, making it a preferred choice among foreign buyers seeking trusted and effective formulations.

MEDIWELL PHARMACEUTICALS

Mumbai, India

Business Operations: Manufacturer, Merchant, Service Provider

Contact us for


By clicking on ‘Send Trade Enquiry’, you agree to our terms & condition and user policies

IvrWell-12 is a premium-quality antiparasitic formulation containing Ivermectin 12 mg, designed to meet pharmaceutical standards. It is widely used for the treatment and prevention of various parasitic infections, including intestinal worms, scabies, and other external or internal infestations.


Manufactured in WHO-GMP and ISO-certified facilities, IvrWell-12 ensures consistent quality, safety, and efficacy. Its single-dose oral administration offers convenience and high patient compliance, making it a preferred choice in both public health programs and clinical use worldwide.

Key Features:


  • Active Ingredient: Ivermectin 12 mg
  • Dosage Form: Oral tablet
  • Therapeutic Category: Antiparasitic / Anthelmintic
  • Export Benefits: Competitive pricing, reliable global supply chain, and customizable packaging options
  • IvrWell-12 is trusted by healthcare providers and distributors across global markets for its proven performance, regulatory compliance, and strong export support, making it an ideal product for international pharmaceutical trade.
Established in: 2025
Bussiness Type: Sole Proprietorship
Bussiness Type: Manufacturer, Merchant, Service Provider
MSME: Yes
Export Turnover (3 years): US$500,000 - US$1,000,000
Countries would like to export to: Australia, Germany, Kenya, Russia, South Africa, Turkey, United Kingdom, United States, Netherlands The, Belgium, Italy, Hong Kong S.A.R., Ireland
No of employees: 1-10

Related Products